Hits and misses of the national vaccine rollout – experts weigh in

Hits and misses of the national vaccine rollout – experts weigh in

Government has been criticised for the slow pace of the country’s vaccine rollout which started on 17 May 2021. Elri Voigt spoke to experts to hear what is being done right in this vaccine rollout and where improvements are needed.

Read More

COVID-19: Numbers escalating in Free State schools

COVID-19: Numbers escalating in Free State schools

While it is uncertain when teachers in the Free State will receive vaccinations during this third wave, the number of COVID-19 infections and deaths in the province’s schools continues to increase. Refilwe Mochoari reports.

Read More

Trial of potentially variant-proof vaccine ongoing in Western Cape

Trial of potentially variant-proof vaccine ongoing in Western Cape

An experimental COVID-19 vaccine currently in Phase I trials being run by the University of Cape Town has a unique design that might allow it to offer better protection against current and future variants of the SARS-CoV-2 virus. Elri Voigt provides an update on the trial and unpacks the science behind this vaccine candidate.

Read More

Like a “blanket of fatigue” – Inside Groote Schuur’s long-COVID clinic

Like a “blanket of fatigue” – Inside Groote Schuur’s long-COVID clinic

As a third wave of COVID-19 looms in the Western Cape, a group of doctors at Groote Schuur Hospital’s Post-COVID-19 Lung Disease Clinic are treating patients who have recovered from COVID-19 but who suffer lingering symptoms such as fatigue and shortness of breath. Bienne Huisman paid them a visit.

Read More

COVID-19: What is the correct way to report vaccine-related adverse events?

COVID-19: What is the correct way to report vaccine-related adverse events?

Phase two of South Africa’s COVID-19 vaccine rollout is underway and members of the public are being asked to report any mild, moderate or severe adverse events experienced after receiving their jabs. Adele Baleta explains what the correct way is to report adverse events after vaccination.

Read More

COVID-19 still impacting medical and traditional circumcision in the Eastern Cape

COVID-19 still impacting medical and traditional circumcision in the Eastern Cape

The COVID-19 pandemic and related restrictions have disrupted both traditional male circumcisions and voluntary male circumcisions in the Eastern Cape. Luvuyo Mehlwana reports.

Read More

COVID-19: One week of vaccines: What are we doing well? What can be done better?

COVID-19: One week of vaccines: What are we doing well? What can be done better?

It has been a week since South Africa started its mass rollout for 60-year-olds and older. Nathan Geffen and Marcus Low assess the rollout so far.

Read More

In-depth: What will it take to actually make mRNA vaccines in SA

In-depth: What will it take to actually make mRNA vaccines in SA

Messenger RNA (mRNA) vaccines, such as the COVID-19 vaccines made by Moderna and Pfizer/BioNTech, have been hailed for their manufacturing advantages over conventional vaccines – so much so that African leaders such as President Cyril Ramaphosa has called for mRNA production capacity to be developed in Africa. Catherine Tomlinson examines why mRNA vaccines are easier to make than some other types of vaccines and asks what it will take to build such production capacity.

Read More

Analysis: We need to do for TB vaccines what we’ve done for COVID-19

Analysis: We need to do for TB vaccines what we’ve done for COVID-19

It is little wonder that some TB vaccine researchers suffer from a rare syndrome that understandably threatens their mental health. Symptoms include frustration, impatience, irritability, seemingly inexplicable rage, and in the least resilient, despair. It’s called VJS or vaccine jealousy syndrome, writes Chris Bateman.

Read More

COVID-19: What provinces have planned for older persons

COVID-19: What provinces have planned for older persons

Phase II of South Africa’s vaccination rollout has started. Elri Voigt unpacks how provinces will go about vaccinating those aged 60 and older.

Read More

Behind the scenes: How the first 500 000 vaccine doses administered in SA were secured

Behind the scenes: How the first 500 000 vaccine doses administered in SA were secured

When South Africa’s rollout of the AstraZeneca vaccine was put on hold in early February, a scramble ensued to ensure healthcare workers could be protected. Chris Bateman spoke to Professor Glenda Gray about the behind-the-scenes negotiations that helped secure 500 000 doses of the Johnson & Johnson vaccine – almost all of which have now been used in the Sisonke study.

Read More